🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
12.13
-0.38 (-3.04%)
Nov 20, 2026, 3:04 PM CST

SHE:002275 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
422.25433.13521.53421.3329.53343.72
Depreciation & Amortization
96.296.2110.08115.12114.83106.72
Other Amortization
11.6411.6416.49.619.216.27
Loss (Gain) From Sale of Assets
-0.15-0.15-83.35-1.67-31.24-15.12
Asset Writedown & Restructuring Costs
0.730.730.850.1617.74
Loss (Gain) From Sale of Investments
-13.83-13.83-10.84-6.73-5.87-9.65
Provision & Write-off of Bad Debts
22.8522.859.220.013.911.28
Other Operating Activities
1.5823.5626.9716.738.7118.05
Change in Accounts Receivable
216.7216.7-71.5672.95-88.25-66.83
Change in Inventory
-13.12-13.1220.54-27.2333.67-99.73
Change in Accounts Payable
-72.53-72.5346.36-80.3584.98120.16
Change in Other Net Operating Assets
--2.8530.4865.78-
Operating Cash Flow
675.26708.12588.33549.25528.67410.24
Operating Cash Flow Growth
-14.11%20.36%7.12%3.89%28.87%-31.40%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-94.62-86.94-82.18-76.4-62.27-144.09
Sale of Property, Plant & Equipment
-1.090.060.4653.692.7527.73
Investment in Securities
-180.64-318.61-246.22473.49957.69-39.94
Other Investing Activities
87.8-23.72-21.48-545.01-978.439.33
Investing Cash Flow
-188.55-429.21-349.41-94.22-80.24-146.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-355476.7410.7159.7276.68
Total Debt Issued
296.12355476.7410.7159.7276.68
Long-Term Debt Repaid
--445.13-398.98-354.24-315.71-192.87
Lease Payments
-16.45-16.45-19.57-20.65-20.1-24.14
Total Debt Repaid
-584-445.13-398.98-354.24-315.71-192.87
Net Debt Issued (Repaid)
-287.88-90.1377.7256.46-156.0183.81
Issuance of Common Stock
----84.1-
Common Dividends Paid
-304.81-341.05-336.14-427.77-570.88-453.7
Other Financing Activities
109.2656.6250.119.74-4050
Financing Cash Flow
-483.44-374.56-208.31-361.57-682.78-319.89

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-6.84-0.091.060.868.31-2.71
Net Cash Flow
-3.57-95.7431.6894.32-226.04-59.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
580.64621.18506.16472.85466.4266.15
Free Cash Flow Growth
0.19%22.72%7.04%1.38%75.24%-32.19%
Free Cash Flow Margin
28.64%30.36%23.07%21.77%23.80%15.29%
Free Cash Flow Per Share
0.991.060.860.810.790.47
Levered Free Cash Flow
419.88502.03294.68349.37249.38156.13
Unlevered Free Cash Flow
431.67514.44303.33359.59262.03167.51
Free Cash Flow After Leases
564.18604.73486.59452.2446.3242.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
314.27339.79334.58389.12251.67247.99
Change in Working Capital
133.98133.98-2.53-5.2898.6-48.77